Research and Development

Showing 15 posts of 9603 posts found.

Renovo cuts jobs after takeover talks fail

September 18, 2009 Research and Development Renovo

UK biotech Renovo is planning to reduce its headcount by over a third after a takeover approach from an unnamed …

Merck’s osteoporosis candidate shows some promise in trials

September 16, 2009 Research and Development, Sales and Marketing Cancer, Merck

Merck & Co's investigational cathepsin K inhibitor odanacatib has shown some promise in a trial to treat osteoporosis in postmenopausal …

Conservatives leading on ‘industrial policy’ say CBI

September 16, 2009 Research and Development ABPI, hc, reform

 A change of government would benefit UK pharma, according to the Confederation of British Industry, which says the industry might …

Roche divests protein expression portfolio

September 10, 2009 Research and Development Roche, genomics

 Roche has sold its cell-free protein expression kits business for an undisclosed sum.Berlin-based company RiNA will take control of the …

Expanding clinical trials in India: answering the need for training

September 8, 2009 Research and Development India, clinical trials

 India is widely seen as the most exciting country in the clinical research world. Its potential to deliver large numbers …

Herceptin scientist wins Janssen award for biomedical research

September 8, 2009 Research and Development Herceptin, Janssen

Johnson & Johnson has honoured the career achievements of Axel Ullrich by awarding him with the 2009 Dr Paul Janssen …

Observational studies will help answer growing safety demands

September 8, 2009 Research and Development ICON, drug safety

The pharmaceutical industry is ready to adapt to growing drug safety requirements, but understanding of how it can capture safety …

Patients on Enbrel work longer, says study

September 7, 2009 Research and Development, Sales and Marketing Enbrel, RA

 Rheumatoid arthritis patients taking Enbrel are able to keep working for longer, according to a new study comparing its affects …

NICE backs limited use of Lilly’s Plavix rival

September 7, 2009 Research and Development Efient, NICE

 NICE has recommended Lilly and Daiichi’s Efient for use on the NHS, giving the blood-thinner drug a boost in its …

Roche and PTC sign CNS research deal

September 4, 2009 Research and Development CNS, Roche

 PTC Therapeutics has signed an early-stage drug discovery deal with Roche that will focus on treatments for central nervous system …

Head-to-head boost for Brilinta over Plavix

September 4, 2009 Research and Development, Sales and Marketing AZ, Brillinta

 AstraZeneca has released details of its brand Brilinta’s performance in head-to-head trials with Plavix, the world’s second biggest-selling drug.Earlier this …

Roche’s MabThera expands licence in leukaemia

September 4, 2009 Research and Development, Sales and Marketing MabThera, Roche

 MabThera has been approved in Europe for use in previously treated chronic lymphocytic leukaemia, which Roche says will offer new …

Merck launches Saflutan in first European markets

September 4, 2009 Research and Development, Sales and Marketing Merck, ophthalmology

Merck's glaucoma drug Saflutan has been launched in the UK and Spain. The manufacturer says more launches are planned in …
The Gateway to Local Adoption Series

Latest content